Clinical Trial Protocol Information

Clinical trial protocol information for active or completed studies are available below.

If you are a patient, physician, or researcher seeking more information about Takeda’s active or completed clinical trials in the Japanese language please click here.

All Clinical Trial Protocol Information



A Single-arm Study of Brentuximab Vedotin in Patients With Relapsed or Refractory Hodgkin Lymphoma Who Are Not Suitable for Stem Cell Transplantation or Multiagent Chemotherapy


A Phase 1 Study of [14C]-MLN9708 to Assess Mass Balance, Pharmacokinetics, and Metabolism in Patients With Advanced Solid Tumors or Lymphomas


An Open-Label, Phase 2 Study to Evaluate the Oral Combination of MLN9708 With Cyclophosphamide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Requiring Systemic Treatment


A Study to Compare the Efficacy and Safety of TAK-390MR and Placebo on the Ability to Maintain Healing in Subjects With Healed Erosive Esophagitis

TAK-375 / EC302

A randomised, double-blind, placebo-controlled study to determine the long-term efficacy and safety of ramelteon in adults with chronic insomnia

TAK-128 (TL-003)

TAK-128 Effects on Diabetic Peripheral Neuropathy


Study of SYR-322 Combined With a Sulfonylurea in the Treatment of Type 2 Diabetes


A Study to Compare the Efficacy and Safety of TAK390MR and Placebo in Treating the Symptoms of Gastroesophageal Reflux Disease (GERD)